Corcept Therapeutics, Inc. (CORT)
42.45
+1.15
(+2.78%)
USD |
NASDAQ |
Jan 23, 11:29
Corcept Therapeutics Research and Development Expense (TTM): 260.35M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Axsome Therapeutics, Inc. | 188.68M |
| Johnson & Johnson | 14.70B |
| United Therapeutics Corp. | 544.30M |
| Ultragenyx Pharmaceutical, Inc. | 699.19M |
| Amicus Therapeutics, Inc. | 142.29M |